The Phillies learned they would be without left hander Daniel Stumpf, 25, for 80 games, in surprising news. The 12th pick in last year’s Rule 5 draft pick from the Royals was suspended for testing positive for the performance-enhancing drug dehydrochlormethyltestosterone, an anabolic steroid, and the Phillies were notified Thursday of the violation. The suspension is effective immediately starting with the Phillies-Padres matinee rubber match today, at 1:05pm.
Barring any postponements in the schedule, Stumpf is eligible to rejoin the club July 10 in Colorado, if the team chooses to retain him.
Adam Groff, Stumpf’s agent, declined for comment, as teammates and club officials were surprised to hear the news.
The club was disappointed, but understood the decision stating, “The Phillies support Major League Baseball’s Joint Prevention and Treatment Program and are disappointed to hear today’s news of Daniel’s violation.”
Stumpf becomes the fifth Phillies player to be suspended under MLB’s new Joint Drug Prevention and Treatment Program while on the active roster. Before, there was Freddy Galvis, Carlos Ruiz, former reliever J.C Romero, and since-traded Antonio Bastardo.
Daniel Stumpf has pitched in three games on the season, compiling 0.2 IP with an ERA of 40.50, allowing 3 runs, and 2 walks.
To take his place on the 25-man roster, fellow LHP Elvis Araujo has been recalled from AAA Lehigh Valley.
photo credit: philly.com